Connor, Clark & Lunn Investment Management (CC&L)’s PDL BioPharma, Inc. PDLI Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PDLI Stock Details PDLI Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-2,167,755	Closed	-$6.83M	–	1094
2020 Q3	$6.83M	Sell	2,167,755 -803,221	-27%	-$2.53M	0.05%	255
2020 Q2	$8.65M	Sell	2,970,976 -764,710	-20%	-$2.23M	0.06%	221
2020 Q1	$10.5M	Sell	3,735,686 -271,650	-7%	-$766K	0.09%	150
2019 Q4	$13M	Sell	4,007,336 -379,702	-9%	-$1.23M	0.09%	160
2019 Q3	$9.48M	Sell	4,387,038 -100,546	-2%	-$217K	0.07%	181
2019 Q2	$14.1M	Sell	4,487,584 -503,889	-10%	-$1.58M	0.09%	159
2019 Q1	$18.6M	Sell	4,991,473 -899,178	-15%	-$3.34M	0.12%	131
2018 Q4	$17.1M	Sell	5,890,651 -77,454	-1%	-$225K	0.12%	133
2018 Q3	$15.7M	Buy	5,968,105 +290,458	+5%	+$764K	0.09%	160
2018 Q2	$13.3M	Buy	5,677,647 +887,945	+19%	+$2.08M	0.07%	185
2018 Q1	$14.1M	Buy	4,789,702 +1,143,153	+31%	+$3.36M	0.09%	165
2017 Q4	$9.99M	Buy	3,646,549 +1,032,437	+39%	+$2.83M	0.06%	204
2017 Q3	$8.86M	Buy	2,614,112 +1,126,399	+76%	+$3.82M	0.05%	222
2017 Q2	$3.68M	Buy	1,487,713 +88,765	+6%	+$219K	0.02%	304
2017 Q1	$3.18M	Buy	1,398,948 +40,073	+3%	+$91K	0.02%	317
2016 Q4	$2.88M	Sell	1,358,875 -36,200	-3%	-$76.7K	0.02%	325
2016 Q3	$4.67M	Sell	1,395,075 -21,800	-2%	-$73K	0.03%	254
2016 Q2	$4.45M	Buy	1,416,875 +3,200	+0.2%	+$10K	0.03%	254
2016 Q1	$4.71M	Buy	1,413,675 +22,000	+2%	+$73.3K	0.04%	234
2015 Q4	$4.93M	Buy	1,391,675 +315,525	+29%	+$1.12M	0.04%	211
2015 Q3	$5.41M	Buy	1,076,150 +901,050	+515%	+$4.53M	0.04%	190
2015 Q2	$1.13M	Buy	+175,100	New	+$1.13M	0.01%	318
2014 Q3	–	Sell	-98,340	Closed	-$1.01M	–	625
2014 Q2	$1.01M	Buy	+98,340	New	+$1.01M	0.01%	321
2014 Q1	–	Sell	-112,434	Closed	-$1.01M	–	849
2013 Q4	$1.01M	Sell	112,434 -113,261	-50%	-$1.02M	0.01%	367
2013 Q3	$1.85M	Sell	225,695 -98,000	-30%	-$803K	0.02%	206
2013 Q2	$2.64M	Buy	+323,695	New	+$2.64M	0.03%	167